Aspira Pathlab & Diagnostics Limited (BOM: 540788)
India
· Delayed Price · Currency is INR
59.10
-1.20 (-1.99%)
At close: Dec 27, 2024
Aspira Pathlab & Diagnostics Revenue
Aspira Pathlab & Diagnostics had revenue of 61.78M INR in the quarter ending September 30, 2024, with 137.25% growth. In the fiscal year ending March 31, 2024, Aspira Pathlab & Diagnostics had annual revenue of 132.05M, down -8.66%.
Revenue
132.05M
Revenue Growth
-8.66%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
115
Market Cap
620.46M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 132.05M | -12.52M | -8.66% |
Mar 31, 2023 | 144.57M | -50.85M | -26.02% |
Mar 31, 2022 | 195.42M | 43.37M | 28.52% |
Mar 31, 2021 | 152.05M | 67.89M | 80.66% |
Mar 31, 2020 | 84.16M | 7.79M | 10.20% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,249.38B |
Tata Consultancy Services | 2,486.92B |
HDFC Bank | 2,761.06B |
Bharti Airtel | 1,554.78B |
ICICI Bank | 1,638.51B |
Infosys | 1,578.13B |
State Bank of India | 3,360.28B |
ITC Limited | 751.35B |